nodes	percent_of_prediction	percent_of_DWPC	metapath
Mexiletine—CYP2E1—Thalidomide—leprosy	0.169	0.185	CbGbCtD
Mexiletine—CYP2E1—Rifampicin—leprosy	0.163	0.179	CbGbCtD
Mexiletine—CYP2B6—Rifampicin—leprosy	0.161	0.177	CbGbCtD
Mexiletine—CYP2E1—Dapsone—leprosy	0.135	0.148	CbGbCtD
Mexiletine—CYP1A2—Thalidomide—leprosy	0.0976	0.107	CbGbCtD
Mexiletine—CYP1A2—Rifampicin—leprosy	0.0945	0.104	CbGbCtD
Mexiletine—CYP3A4—Rifampicin—leprosy	0.0495	0.0544	CbGbCtD
Mexiletine—CYP3A4—Dapsone—leprosy	0.0409	0.0449	CbGbCtD
Mexiletine—Nystagmus—Thalidomide—leprosy	0.00252	0.0288	CcSEcCtD
Mexiletine—Psychotic disorder—Dapsone—leprosy	0.00249	0.0285	CcSEcCtD
Mexiletine—Numbness—Thalidomide—leprosy	0.00217	0.0248	CcSEcCtD
Mexiletine—Pancreatitis—Dapsone—leprosy	0.00216	0.0247	CcSEcCtD
Mexiletine—Blood disorder—Thalidomide—leprosy	0.00216	0.0246	CcSEcCtD
Mexiletine—Sensory loss—Thalidomide—leprosy	0.00208	0.0237	CcSEcCtD
Mexiletine—Atrioventricular block—Thalidomide—leprosy	0.00186	0.0212	CcSEcCtD
Mexiletine—Coordination abnormal—Thalidomide—leprosy	0.00183	0.0209	CcSEcCtD
Mexiletine—Pharyngitis—Dapsone—leprosy	0.00175	0.02	CcSEcCtD
Mexiletine—Tinnitus—Dapsone—leprosy	0.00165	0.0188	CcSEcCtD
Mexiletine—Lightheadedness—Thalidomide—leprosy	0.00161	0.0184	CcSEcCtD
Mexiletine—Vision blurred—Dapsone—leprosy	0.00145	0.0165	CcSEcCtD
Mexiletine—Cardiac failure congestive—Thalidomide—leprosy	0.00144	0.0164	CcSEcCtD
Mexiletine—Libido decreased—Thalidomide—leprosy	0.00141	0.0161	CcSEcCtD
Mexiletine—Amnesia—Thalidomide—leprosy	0.00139	0.0159	CcSEcCtD
Mexiletine—Dermatitis exfoliative—Thalidomide—leprosy	0.00138	0.0158	CcSEcCtD
Mexiletine—Visual disturbance—Thalidomide—leprosy	0.00138	0.0157	CcSEcCtD
Mexiletine—Disturbance in sexual arousal—Thalidomide—leprosy	0.0013	0.0148	CcSEcCtD
Mexiletine—Psychotic disorder—Thalidomide—leprosy	0.00128	0.0146	CcSEcCtD
Mexiletine—Ataxia—Thalidomide—leprosy	0.00123	0.014	CcSEcCtD
Mexiletine—Liver function test abnormal—Thalidomide—leprosy	0.00121	0.0138	CcSEcCtD
Mexiletine—Dry skin—Thalidomide—leprosy	0.0012	0.0137	CcSEcCtD
Mexiletine—Cramp muscle—Thalidomide—leprosy	0.00118	0.0134	CcSEcCtD
Mexiletine—Dysphagia—Thalidomide—leprosy	0.00113	0.0129	CcSEcCtD
Mexiletine—Pancreatitis—Thalidomide—leprosy	0.00111	0.0126	CcSEcCtD
Mexiletine—Angina pectoris—Thalidomide—leprosy	0.0011	0.0126	CcSEcCtD
Mexiletine—Neutropenia—Thalidomide—leprosy	0.00106	0.0121	CcSEcCtD
Mexiletine—Erectile dysfunction—Thalidomide—leprosy	0.00104	0.0119	CcSEcCtD
Mexiletine—Gastrointestinal pain—Dapsone—leprosy	0.00103	0.0117	CcSEcCtD
Mexiletine—Drowsiness—Thalidomide—leprosy	0.00101	0.0115	CcSEcCtD
Mexiletine—Depression—Thalidomide—leprosy	0.001	0.0115	CcSEcCtD
Mexiletine—Stevens-Johnson syndrome—Thalidomide—leprosy	0.000998	0.0114	CcSEcCtD
Mexiletine—Abdominal pain—Dapsone—leprosy	0.000992	0.0113	CcSEcCtD
Mexiletine—Body temperature increased—Dapsone—leprosy	0.000992	0.0113	CcSEcCtD
Mexiletine—Agranulocytosis—Thalidomide—leprosy	0.00094	0.0107	CcSEcCtD
Mexiletine—Bradycardia—Thalidomide—leprosy	0.00092	0.0105	CcSEcCtD
Mexiletine—Hepatitis—Thalidomide—leprosy	0.000904	0.0103	CcSEcCtD
Mexiletine—Hypoaesthesia—Thalidomide—leprosy	0.000899	0.0103	CcSEcCtD
Mexiletine—Pharyngitis—Thalidomide—leprosy	0.000897	0.0102	CcSEcCtD
Mexiletine—Visual impairment—Thalidomide—leprosy	0.000871	0.00995	CcSEcCtD
Mexiletine—Erythema multiforme—Thalidomide—leprosy	0.000855	0.00976	CcSEcCtD
Mexiletine—Tinnitus—Thalidomide—leprosy	0.000843	0.00962	CcSEcCtD
Mexiletine—Arrhythmia—Thalidomide—leprosy	0.000808	0.00922	CcSEcCtD
Mexiletine—Alopecia—Thalidomide—leprosy	0.000799	0.00912	CcSEcCtD
Mexiletine—Vomiting—Dapsone—leprosy	0.000798	0.00911	CcSEcCtD
Mexiletine—Headache—Dapsone—leprosy	0.000786	0.00897	CcSEcCtD
Mexiletine—Tension—Thalidomide—leprosy	0.000772	0.00882	CcSEcCtD
Mexiletine—Dysgeusia—Thalidomide—leprosy	0.000771	0.0088	CcSEcCtD
Mexiletine—Nervousness—Thalidomide—leprosy	0.000764	0.00873	CcSEcCtD
Mexiletine—Muscle spasms—Thalidomide—leprosy	0.000757	0.00864	CcSEcCtD
Mexiletine—Nausea—Dapsone—leprosy	0.000745	0.00851	CcSEcCtD
Mexiletine—Vision blurred—Thalidomide—leprosy	0.000742	0.00847	CcSEcCtD
Mexiletine—Tremor—Thalidomide—leprosy	0.000737	0.00842	CcSEcCtD
Mexiletine—Ill-defined disorder—Thalidomide—leprosy	0.00073	0.00834	CcSEcCtD
Mexiletine—Malaise—Thalidomide—leprosy	0.00071	0.0081	CcSEcCtD
Mexiletine—Syncope—Thalidomide—leprosy	0.000706	0.00806	CcSEcCtD
Mexiletine—Leukopenia—Thalidomide—leprosy	0.000704	0.00804	CcSEcCtD
Mexiletine—Palpitations—Thalidomide—leprosy	0.000695	0.00794	CcSEcCtD
Mexiletine—Loss of consciousness—Thalidomide—leprosy	0.000692	0.0079	CcSEcCtD
Mexiletine—Convulsion—Thalidomide—leprosy	0.000682	0.00778	CcSEcCtD
Mexiletine—Hypertension—Thalidomide—leprosy	0.000679	0.00776	CcSEcCtD
Mexiletine—Arthralgia—Thalidomide—leprosy	0.00067	0.00765	CcSEcCtD
Mexiletine—Chest pain—Thalidomide—leprosy	0.00067	0.00765	CcSEcCtD
Mexiletine—Discomfort—Thalidomide—leprosy	0.000662	0.00756	CcSEcCtD
Mexiletine—Dry mouth—Thalidomide—leprosy	0.000655	0.00748	CcSEcCtD
Mexiletine—Confusional state—Thalidomide—leprosy	0.000648	0.00739	CcSEcCtD
Mexiletine—Oedema—Thalidomide—leprosy	0.000642	0.00733	CcSEcCtD
Mexiletine—Shock—Thalidomide—leprosy	0.000632	0.00721	CcSEcCtD
Mexiletine—Thrombocytopenia—Thalidomide—leprosy	0.000629	0.00718	CcSEcCtD
Mexiletine—Hyperhidrosis—Thalidomide—leprosy	0.000621	0.00709	CcSEcCtD
Mexiletine—Hypotension—Thalidomide—leprosy	0.0006	0.00685	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Thalidomide—leprosy	0.000585	0.00668	CcSEcCtD
Mexiletine—Paraesthesia—Thalidomide—leprosy	0.000577	0.00658	CcSEcCtD
Mexiletine—Dyspnoea—Thalidomide—leprosy	0.000573	0.00654	CcSEcCtD
Mexiletine—Somnolence—Thalidomide—leprosy	0.000571	0.00652	CcSEcCtD
Mexiletine—Dyspepsia—Thalidomide—leprosy	0.000565	0.00645	CcSEcCtD
Mexiletine—Fatigue—Thalidomide—leprosy	0.000554	0.00632	CcSEcCtD
Mexiletine—Pain—Thalidomide—leprosy	0.000549	0.00627	CcSEcCtD
Mexiletine—Constipation—Thalidomide—leprosy	0.000549	0.00627	CcSEcCtD
Mexiletine—Feeling abnormal—Thalidomide—leprosy	0.000529	0.00604	CcSEcCtD
Mexiletine—Gastrointestinal pain—Thalidomide—leprosy	0.000525	0.006	CcSEcCtD
Mexiletine—Body temperature increased—Thalidomide—leprosy	0.000508	0.0058	CcSEcCtD
Mexiletine—Abdominal pain—Thalidomide—leprosy	0.000508	0.0058	CcSEcCtD
Mexiletine—Hypersensitivity—Thalidomide—leprosy	0.000473	0.0054	CcSEcCtD
Mexiletine—Asthenia—Thalidomide—leprosy	0.000461	0.00526	CcSEcCtD
Mexiletine—Diarrhoea—Thalidomide—leprosy	0.000439	0.00502	CcSEcCtD
Mexiletine—Dizziness—Thalidomide—leprosy	0.000425	0.00485	CcSEcCtD
Mexiletine—Vomiting—Thalidomide—leprosy	0.000408	0.00466	CcSEcCtD
Mexiletine—Rash—Thalidomide—leprosy	0.000405	0.00462	CcSEcCtD
Mexiletine—Dermatitis—Thalidomide—leprosy	0.000405	0.00462	CcSEcCtD
Mexiletine—Headache—Thalidomide—leprosy	0.000402	0.00459	CcSEcCtD
Mexiletine—Nausea—Thalidomide—leprosy	0.000381	0.00436	CcSEcCtD
Mexiletine—SCN10A—peripheral nervous system—leprosy	0.000302	0.213	CbGeAlD
Mexiletine—SCN10A—nerve—leprosy	0.000235	0.166	CbGeAlD
Mexiletine—SCN9A—tendon—leprosy	8.54e-05	0.0602	CbGeAlD
Mexiletine—AHR—tendon—leprosy	8.34e-05	0.0588	CbGeAlD
Mexiletine—SCN4A—tendon—leprosy	7.62e-05	0.0537	CbGeAlD
Mexiletine—SCN9A—testis—leprosy	7.08e-05	0.0499	CbGeAlD
Mexiletine—AHR—testis—leprosy	6.9e-05	0.0487	CbGeAlD
Mexiletine—SCN4A—testis—leprosy	6.31e-05	0.0445	CbGeAlD
Mexiletine—SCN4A—nervous system—leprosy	6.19e-05	0.0437	CbGeAlD
Mexiletine—SCN2A—nervous system—leprosy	5.48e-05	0.0386	CbGeAlD
Mexiletine—SCN10A—nervous system—leprosy	5.29e-05	0.0373	CbGeAlD
Mexiletine—SCN5A—nervous system—leprosy	4.8e-05	0.0339	CbGeAlD
Mexiletine—CYP2B6—skin of body—leprosy	3.92e-05	0.0276	CbGeAlD
Mexiletine—CYP2E1—tendon—leprosy	2.8e-05	0.0197	CbGeAlD
Mexiletine—CYP2B6—testis—leprosy	2.47e-05	0.0174	CbGeAlD
Mexiletine—CYP2B6—nervous system—leprosy	2.42e-05	0.0171	CbGeAlD
Mexiletine—CYP2E1—testis—leprosy	2.32e-05	0.0163	CbGeAlD
Mexiletine—CYP2E1—nervous system—leprosy	2.28e-05	0.016	CbGeAlD
Mexiletine—CYP2D6—testis—leprosy	1.84e-05	0.0129	CbGeAlD
Mexiletine—CYP3A4—nervous system—leprosy	1.83e-05	0.0129	CbGeAlD
Mexiletine—CYP2D6—nervous system—leprosy	1.8e-05	0.0127	CbGeAlD
